HealthEquity

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

HQY reports strong Q1 performance, faces challenges in seasonality and yield expectations

HQY's Q1 performance reflects strong growth and positive financial results, driven by increased HSA adoption and employer interest. However, the company faces challenges related to seasonality and yield expectations. To capitalize on opportunities, HQY should focus on reaching its enhanced rates target and addressing service fee pressures.

HealthEquity reports robust Q2 performance and eyes market expansion

HealthEquity's strong Q2 performance, driven by revenue and EBITDA growth, is supported by the enhanced rates product and expanded network partner footprint. While facing short-term challenges in interchange revenue and M&A environment changes, the company is well-positioned to capitalize on opportunities presented by market dynamics and regulatory discussions.

HealthEquity reports robust Q3 performance and optimistic fiscal '25 outlook

HealthEquity's Q3 performance showcased strong financial results, with raised fiscal '24 guidance and optimistic initial fiscal '25 guidance. The company is well-positioned to navigate challenges and capitalize on opportunities, particularly in expanding its market presence and enhancing customer satisfaction.

HealthEquity (HQY) posts record earnings, eyes growth through innovation

HealthEquity (HQY) delivered strong financial results, exceeding expectations and demonstrating growth across key metrics.
While facing challenges in certain business segments, the company's focus on technology, customer experience, and long-term quality positions it well for the future.
Opportunities for R&D acceleration, innovation through M&A, and expansion of product offerings present avenues for sustained growth and competitive advantage.

HealthEquity reports robust Q1 results, raises fiscal '24 guidance

HealthEquity's Q1 performance reflects strong financial growth and stability, with revenue, EBITDA, and HSA metrics showing positive trends.
The company's proactive approach to guidance revision, service fee optimization, and strategic partnerships positions it well for future success.
Challenges in managing fee pressures, COBRA impact, and M&A environment slowdown require focused strategies for sustained growth and market leadership.

HealthEquity reports robust Q2 results, eyes growth amid market shifts

HealthEquity's Q2 results reflect strong financial performance and strategic positioning for future growth.
Despite challenges in revenue consistency and market dynamics, the company's strengths in service quality and market leadership are key assets.
Opportunities in revenue growth, legislative changes, and market demand provide avenues for HealthEquity's continued success.

HealthEquity reports strong Q3 growth and bullish outlook for fiscal '25

HealthEquity's Q3 2024 earnings call highlighted impressive financial performance, strategic acquisitions, and optimistic guidance for fiscal '25, underlining the company's growth trajectory and market positioning.
While facing challenges in integrating acquisitions, maintaining competitive pricing, and managing asset maturation, HealthEquity remains focused on growth opportunities through enhanced yield products and consumer empowerment.
The company's emphasis on stability, profitability, and reinvestments, coupled with a proactive approach to engaging investors, sets the stage for continued success and market differentiation in the evolving healthcare landscape.

HealthEquity reports robust Q4 earnings, eyes growth through innovation

HealthEquity delivered strong financial results in Q4 2024, showcasing robust revenue growth and operational performance.
The company's focus on enhancing shareholder value, strategic mergers, and technology investments positions it well for future growth.
Challenges in pricing pressures and technology spend trends require careful navigation, while opportunities in HSA cash rates and digital innovations offer avenues for expansion.
Overall, HealthEquity's performance highlights resilience, strategic foresight, and a commitment to driving long-term value for stakeholders.

HealthEquity reports robust Q1 results, eyes cost savings and growth

HealthEquity's Q1 performance reflects strong growth in revenue, EBITDA, and HSA assets, underlining its market strength and operational efficiency.
The company's focus on cost savings, customer experience enhancement, and new sales growth positions it well for future success and market expansion.
While facing challenges in transitioning processes and managing costs, HealthEquity is leveraging opportunities in technology and market expansion to drive continued growth.

HealthEquity reports robust Q2 growth, unveils innovative healthcare payment options

HealthEquity's Q2 performance reflects strong growth and strategic initiatives to enhance healthcare payment options.
While facing challenges in margins and market conditions, the company's focus on innovation and team efforts bode well for future success.
Opportunities lie in leveraging HPAs, digital integration, and market expansion to drive continued growth and customer value.
Overall, HealthEquity's performance and outlook demonstrate resilience and a commitment to driving healthcare financial solutions.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

HealthEquity's (HQY) strength in HSA raises optimism about the stock.

3 Reasons to Add HealthEquity (HQY) Stock to Your Portfolio

Expert panel to explore key trends in healthcare cost management, AI in healthcare, and elevating benefits literacy among a diverse workforce Expert panel to explore key trends in healthcare cost management, AI in healthcare, and elevating benefits literacy among a diverse workforce

HealthEquity Forum to Unveil 2024's Top Employee Benefits Trends: AI, Cost Management, and More

HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in the majority of its segments, in the third quarter of fiscal 2024.

HealthEquity (HQY) Q3 Earnings Surpass Estimates, Margins Up

HealthEquity, Inc. (NASDAQ:HQY ) Q3 2024 Earnings Conference Call December 5, 2023 4:30 PM ET Company Participants Richard Putnam - Investor Relations Jon Kessler - President and Chief Executive Officer James Lucania - Executive Vice President and Chief Financial Officer Conference Call Participants Greg Peters - Raymond James Stan Berenshteyn - Wells Fargo Allen Lutz - Bank of America David Larsen - BTIG Anne Samuel - JP Morgan George Hill - Deutsche Bank Mark Marcon - Baird Jack Wallace - Guggenheim Operator Hello and welcome to the HealthEquity's Third Quarter 2024 Earnings Call. All participants will be in listen-only mode.

HealthEquity, Inc. (HQY) Q3 2024 Earnings Call Transcript

HealthEquity (HQY) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.38 per share a year ago.

HealthEquity (HQY) Beats Q3 Earnings and Revenue Estimates

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended October 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HealthEquity (HQY) Reports Q3 Earnings: What Key Metrics Have to Say

Highlights of the third quarter include: Revenue of $249.2 million, an increase of 15% compared to $216.1 million in Q3 FY23. Net income of $14.7 million, compared to net loss of $1.6 million in Q3 FY23, with non-GAAP net income of $52.2 million, an increase of 61% compared to $32.4 million in Q3 FY23.

HealthEquity Reports Third Quarter Ended October 31, 2023 Financial Results

HealthEquity (HQY) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, HQY broke through the 20-day moving average, which suggests a short-term bullish trend.

HealthEquity (HQY) Just Overtook the 20-Day Moving Average

Get a deeper insight into the potential performance of HealthEquity (HQY) for the quarter ended October 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Curious about HealthEquity (HQY) Q3 Performance? Explore Wall Street Estimates for Key Metrics

HealthEquity has seen its share price trade sideways in 2023 but has the potential for long-term growth with certain competencies. Q2 earnings showed an 18% increase in revenue and strong asset growth, setting the stage for a strong H2 FY'23. Short-term investors may be deterred by the stock's high valuation, but longer-term investors should consider HQY's growth potential, FCF/share thrown off + business returns.

HealthEquity: Long-Term Fundamentals Supported In Business Returns + FCF Growth

Alibaba

GoPro

GrubHub

LendingClub

Paycom Software

TriNet Group

Zendesk

If you could go back to 2014, odds are you'd want to invest in Bitcoin.

8 Companies That Had Their IPO in 2014: Best and Worst Performers

Here is how HealthEquity (HQY) and Corbus Pharmaceuticals (CRBP) have performed compared to their sector so far this year.

Are Medical Stocks Lagging HealthEquity (HQY) This Year?

InterDigital

Vericel

Some of the most followed information in the stock market besides earnings releases are analyst recommendations. These are expert analyses that cover various companies that have a high potential for return on investment or industries in which they specialize.

3 Strong Buy Stocks Set to Take Off in the Coming Months

DRAPER, Utah , Nov. 08, 2023 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced plans to release its third quarter of fiscal 2024 financial results following the close of regular stock market trading hours on Tuesday, December 5, 2023. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, December 5, 2023, at 4:30 p.m. ET during which management will review the Company's third quarter results.

HealthEquity Sets Date to Announce Third Quarter Results

DRAPER, Utah, Nov. 07, 2023 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation's largest health savings account (“HSA”) custodian, has been recognized as a Top Place to Work in nearly a dozen regional rankings around the country. The awards, which are based largely on workforce feedback, underscore HealthEquity's commitment to foster a culture that empowers its team members.

HealthEquity Named Top Workplace in Rankings Nationwide

HealthEquity (HQY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why HealthEquity (HQY) Could Beat Earnings Estimates Again

HealthEquity (HQY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Down -8.48% in 4 Weeks, Here's Why You Should You Buy the Dip in HealthEquity (HQY)

Elevance Health Inc

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or HealthEquity (HQY). But which of these two stocks is more attractive to value investors?

ELV vs. HQY: Which Stock Is the Better Value Option?

HealthEquity has sailed relatively smoothly since the Fed's stance on interest rates rocked the stock market. In fact, HQY stock has thrived.

HealthEquity Shields Investors From The Fed — And The IRS — With HSA Accounts

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or HealthEquity (HQY). But which of these two companies is the best option for those looking for undervalued stocks?

ELV vs. HQY: Which Stock Should Value Investors Buy Now?

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock?

HealthEquity (HQY) Up 4% Since Last Earnings Report: Can It Continue?

HealthEquity (HQY) is set to receive the Conduent's HSA portfolio as a part of an agreement signed by the companies earlier this month. The deal is likely to boost HQY's business in 2024 and beyond.

HealthEquity (HQY) to Add Conduent's HSA Accounts in 2024

3 Reasons to Hold HealthEquity (HQY) Stock in Your Portfolio

FLORHAM PARK, N.J. and DRAPER, Utah, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business solutions and services company, and HealthEquity, Inc. (Nasdaq: HQY), the nation's largest health savings account (HSA) administrator, today announced that they have entered into a definitive agreement to transfer BenefitWallet's Health Savings Account (HSA) portfolio to HealthEquity.

UPDATE: Conduent's BenefitWallet HSA Portfolio Moving to HealthEquity

HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in all its segments, in the second quarter of fiscal 2024.

News for HealthEquity Stock (HQY)